Steglatro Tablets 5 Milligrams (Ertugliflozin L-Pyroglutamic Acid)

Adult dose

The recommended starting dose of this medication is 5 mg once daily for monotherapy and in combination therapy with other hypoglycemic agents such as metformin. This medication should be administered orally once daily in the morning regardless of meals. If patients tolerate the 5 mg dose well and additional blood sugar control is needed, the dose may be increased to 15 mg once daily.

This medication should not be administered to certain patients. First, it is not used in patients who have had severe allergic reactions to the main ingredient or excipients of this drug, type 1 diabetes patients, patients with diabetic ketoacidosis, patients with significantly impaired kidney function or those undergoing dialysis. Additionally, this medication contains lactose, so patients with genetic conditions such as lactose intolerance or galactose intolerance should not take it. Patients at risk of reduced blood volume or low blood pressure should use this medication with caution. In particular, patients with poor kidney function, elderly patients, and those taking diuretics should carefully monitor their blood status before treatment and closely observe during treatment as they may experience blood volume reduction and hypotension. In cases of severe congestive heart failure, the use of this medication is not recommended. This medication can cause a serious metabolic disorder known as ketoacidosis, so if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, consult a doctor immediately. There may be a tendency for fungal infections to occur in the genital area, so it's important to seek treatment if there are signs of infection. While taking this medication, side effects such as headaches, urinary tract infections, vulvar itching, increased urination, and thirst may occur, so it's important to be aware of these symptoms. Regular kidney function tests are necessary to ensure that there are no abnormalities. Additionally, this medication may increase the risk of hypoglycemia, requiring careful monitoring of blood sugar levels. Women who are pregnant or breastfeeding should not use this medication and should stop taking it immediately if pregnancy is confirmed. The safety of this medication in children and adolescents has not been established, so it is advisable not to use it. Elderly patients should take caution as they may experience side effects related to reduced blood volume more frequently. Patients with severe impairment of kidney or liver function should not use this medication or should use it cautiously. In the event of an overdose, appropriate treatment should be given according to the symptoms, and it is not clear whether this medication can be removed by dialysis. Finally, this medication should be stored out of reach of children, not transferred to other containers, and handled safely.

Serious side effects

Hypotension due to decreased blood volume, syncope, orthostatic hypotension, ketoacidosis, acute kidney injury, renal impairment, acute generalized renal failure, limb amputation, urosepsis, pyelonephritis, necrotizing fasciitis of the perineum (Fournier's gangrene), severe urinary tract infection

Mild side effects

Fungal infection in the female genital area, fungal infection in the male genital area, urinary tract infection, headache, vulvar itching, increased urination, nasopharyngitis, back pain, weight loss, thirst, increase in low-density lipoprotein cholesterol (LDL-C), rise in hemoglobin, rise in serum phosphate, hypoglycemia

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

Pink, bilaterally convex, triangular film-coated tablet with '701' engraved on one side.

Package unit

28 tablets